A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Anxiety Disorder Social, Anxiety

In brief

The goal of this study is to see whether Botox is an effective treatment for social anxiety disorder (SAD). Participants will complete two short surveys on depression and anxiety symptoms, receive a one-time injection of Botox, and complete the depression and anxiety survey 4 weeks after injection and again at 8 weeks after injection.

Key facts

Study ID

NCT03078270

Run by

Daniel Lieberman

People needed

4

Starts

2017-02-01

Expected to finish

2017-09-12

Last updated by the study team

2019-01-23

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• primary diagnosis of social anxiety disorder
• women of childbearing potential on an acceptable form of birth control and are not pregnant or lactating

You may not qualify if…

• has ever been treated with botulinum toxin A
• has another Axis I diagnosis within in the 6-months prior to screening
• history of substance abuse within 2-months of screening
• current or recent suicidality
• scoring greater than 2 on Beck Depression Inventory (BDI) suicidality question
• psychotic or bipolar disorder
• unstable medical condition
• changes in medication or psychotherapy treatment in the month prior to screening
• significant risk of committing homicide

Where it is running

• GW University Medical Faculty Associated — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.